Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Prednisone
Related studies linked through entity extraction aliases.
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE2
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Corticosteroids for COVID-19
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- TERMINATED
- Phase
- PHASE1
The Impact of Prednisone on Semen Parameters and Pregnancy Rates Post Vasectomy Reversal
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma
- Status
- TERMINATED
- Phase
- PHASE3
PROUD Study - Preventing Opioid Use Disorders
- Status
- TERMINATED
- Phase
- PHASE4
Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Different Immunosuppressive Treatment in iMN
- Status
- RECRUITING
- Phase
- PHASE3
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)
- Status
- TERMINATED
- Phase
- PHASE1
Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation
- Status
- RECRUITING
- Phase
- PHASE2
Single and Multiple Ascending Dose Study of CORT125329 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE2